Plasma Lipocalin Concentrations in Relation to Visceral Fat, Risk Factor for Endometrial Cancer

Authors

  • Razvan CIORTEA “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania, Department of Obstetrics and Gynecology
  • Mihaela OANCEA “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania, Department of Obstetrics and Gynecology
  • Ciprian PORUMB “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania, Department of Obstetrics and Gynecology
  • Andrei MALUTAN “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania, Department of Obstetrics and Gynecology
  • Daria POP “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania, Department of Obstetrics and Gynecology
  • Carmen BUCURI “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania, Department of Obstetrics and Gynecology
  • Andreea BOBRIC “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania, Department of Obstetrics and Gynecology
  • Dan MIHU “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania, Department of Obstetrics and Gynecology

Keywords:

Endometrial cancer, Lipocalin, Ultrasonography, Visceral fat.

Abstract

Objective: The study aims to evaluate the presence of a correlation between visceral fat assessed by ultrasonography and the plasmatic level of lipocalin in patients diagnosed with endometrial cancer. Material and Method: The study is a case-control analysis including 2 groups of patients: group I – 44 patients diagnosed with endometrial cancer, group II – 44 patients without gynecological pathology or inflammatory disorders. After the clinical examination and anthropometric measurements, these patients underwent ultrasonography (US) examination, in view of determining the visceral fat. At the patients included in this study, we also determined the plasmatic levels for lipocalin. Results: At the patients diagnosed with endometrial cancer, the intraabdominal fat area evaluated by US and the plasmatic level of lipocalin is significantly larger (p<0.0001) compared to the control group. A correlation was also found between the intraperitoneal fat area evaluated by US and the plasmatic level of lipocalin. Conclusions: The measurement of the intraperitoneal fat by US in correlation with the plasmatic level of lipocalin can be a screening method for endometrial cancer in obese patients.

Author Biography

Razvan CIORTEA, “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania, Department of Obstetrics and Gynecology

Department of Obstetrics and Gynecology

Downloads

Published

31.03.2014

How to Cite

1.
CIORTEA R, OANCEA M, PORUMB C, MALUTAN A, POP D, BUCURI C, BOBRIC A, MIHU D. Plasma Lipocalin Concentrations in Relation to Visceral Fat, Risk Factor for Endometrial Cancer. Appl Med Inform [Internet]. 2014 Mar. 31 [cited 2024 Jul. 21];34(1):1-9. Available from: https://ami.info.umfcluj.ro/index.php/AMI/article/view/454

Issue

Section

Articles